These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 32831522)
1. Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease. Belhassan A; Chtita S; Zaki H; Lakhlifi T; Bouachrine M Bioinformation; 2020; 16(5):404-410. PubMed ID: 32831522 [TBL] [Abstract][Full Text] [Related]
2. Unrevealing sequence and structural features of novel coronavirus using Ortega JT; Serrano ML; Pujol FH; Rangel HR EXCLI J; 2020; 19():400-409. PubMed ID: 32210741 [TBL] [Abstract][Full Text] [Related]
3. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694 [TBL] [Abstract][Full Text] [Related]
4. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug. Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393 [TBL] [Abstract][Full Text] [Related]
5. Investigation of Some Antiviral Hagar M; Ahmed HA; Aljohani G; Alhaddad OA Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486229 [TBL] [Abstract][Full Text] [Related]
6. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase. Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and investigation of anti-COVID19 ability of ferrocene Schiff base derivatives by quantum chemical and molecular docking. Abbas G; Irfan A; Ahmed I; Al-Zeidaneen FK; Muthu S; Fuhr O; Thomas R J Mol Struct; 2022 Apr; 1253():132242. PubMed ID: 34975177 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and computational study on potential inhibitory action of novel azo imidazole derivatives against COVID-19 main protease (M Chhetri A; Chettri S; Rai P; Mishra DK; Sinha B; Brahman D J Mol Struct; 2021 Feb; 1225():129230. PubMed ID: 32963413 [TBL] [Abstract][Full Text] [Related]
9. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study. Tan Q; Duan L; Ma Y; Wu F; Huang Q; Mao K; Xiao W; Xia H; Zhang S; Zhou E; Ma P; Song S; Li Y; Zhao Z; Sun Y; Li Z; Geng W; Yin Z; Jin Y Bioorg Chem; 2020 Nov; 104():104257. PubMed ID: 32927129 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19. Sharun K; Tiwari R; Yatoo MI; Natesan S; Megawati D; Singh KP; Michalak I; Dhama K Narra J; 2022 Dec; 2(3):e92. PubMed ID: 38449903 [No Abstract] [Full Text] [Related]
11. In silico guided screening of active components of Sharma G; Kumar N; Sharma CS; Mishra SS 3 Biotech; 2023 Oct; 13(10):324. PubMed ID: 37663751 [TBL] [Abstract][Full Text] [Related]
12. Investigation of antiviral substances in Covid 19 by Molecular Docking: In Silico Study. Oner E; Demirhan I; Miraloglu M; Yalin S; Kurutas EB Afr Health Sci; 2023 Mar; 23(1):23-36. PubMed ID: 37545919 [TBL] [Abstract][Full Text] [Related]
13. Density Functional Theory, Molecular Dynamics and AlteQ Studies Approaches of Baimantuoluoamide A and Baimantuoluoamide B to Identify Potential Inhibitors of M Gurushankar K; Jeyaseelan SC; Grishina M; Siswanto I; Tiwari R; Puspaningsih NNT JETP Lett; 2023 May; ():1-10. PubMed ID: 37360903 [TBL] [Abstract][Full Text] [Related]
14. Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations. Baassi M; Moussaoui M; Soufi H; Rajkhowa S; Sharma A; Sinha S; Belaaouad S PLoS One; 2023; 18(4):e0284539. PubMed ID: 37079533 [TBL] [Abstract][Full Text] [Related]
15. A computational study of potential therapeutics for COVID-19 invoking conceptual density functional theory. Saloni ; Kumari D; Ranjan P; Chakraborty T Struct Chem; 2022; 33(6):2195-2204. PubMed ID: 36097582 [TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR, ADME-Tox, and molecular docking of semisynthetic triterpene derivatives as antibacterial and insecticide agents. Daoui O; Mazoir N; Bakhouch M; Salah M; Benharref A; Gonzalez-Coloma A; Elkhattabi S; Yazidi ME; Chtita S Struct Chem; 2022; 33(4):1063-1084. PubMed ID: 35345415 [TBL] [Abstract][Full Text] [Related]
18. A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation. Rakib A; Nain Z; Sami SA; Mahmud S; Islam A; Ahmed S; Siddiqui ABF; Babu SMOF; Hossain P; Shahriar A; Nainu F; Emran TB; Simal-Gandara J Brief Bioinform; 2021 Mar; 22(2):1476-1498. PubMed ID: 33623995 [TBL] [Abstract][Full Text] [Related]
19. Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2. Ouassaf M; Belaidi S; Mogren Al Mogren M; Chtita S; Ullah Khan S; Thet Htar T J King Saud Univ Sci; 2021 Mar; 33(2):101352. PubMed ID: 33558797 [TBL] [Abstract][Full Text] [Related]
20. Copper(II) Inhibition of the SARS-CoV-2 Main Protease. Garza-López RA; Kozak JJ; Gray HB ChemRxiv; 2020 Jul; ():. PubMed ID: 33200118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]